Skip to main content
See every side of every news story
Published loading...Updated

'Designer Xanax' Banned Nationwide After 22 States Urged DEA to Change Its Rules

The DEA classified bromazolam as Schedule I citing no medical use and high abuse risk after Kentucky reported 48 overdose deaths in 2024, prompting a 21-state coalition push.

  • The Drug Enforcement Administration formally added bromazolam to Schedule I, citing its high potential for abuse and lack of accepted medical use.
  • Following alarms from the Northern Kentucky Drug Strike Force, Coleman led a 21-state coalition urging the DEA to schedule bromazolam, a synthetic drug used for counterfeit Xanax.
  • Counterfeit medication sold as "Designer Xanax" contributed to nearly 50 overdose deaths in 2024, proving highly lethal when combined with opioids or depressants.
  • DEA Assistant Administrator Cheri said the emergency move 'closes dangerous gaps' and provides law enforcement with new tools to disrupt access to bromazolam.
  • Officials continue working to stay ahead; Kentuckians can report information about dangerous substances anonymously through the Northern Kentucky Drug Strike Force website, DEA says "closes dangerous gaps".
Insights by Ground AI

18 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources are Center
67% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Lex18 NBC broke the news in on Wednesday, March 18, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal